Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma

New England Journal of Medicine

Volumn 339, Issue 24, 1998, Pages 1734-1738

  Lo, Y M Dennis ^a   Hjelm, N Magnus ^a   Fidler, Carrie ^b   Sargent, Ian L ^b   Murphy, Michael F ^b   Chamberlain, Paul F ^b   Poon, Priscilla M K ^a   Redman, Christopher W G ^b   Wainscoat, James S ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIGEN;

AMNION FLUID ANALYSIS; ARTICLE; BLOOD ANALYSIS; BLOOD GROUP RHESUS SYSTEM; FEMALE; FETUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; NEWBORN HEMOLYTIC DISEASE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

BLOOD GROUPING AND CROSSMATCHING; DNA; FEMALE; FETAL BLOOD; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 0032506669     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199812103392402     Document Type: Article

References (28)

1. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford, England: Blackwell Scientific, 1993:204-45.
2. Clarke CA, Whitfield AG, Mollison PL. Deaths from Rh haemolytic disease in England and Wales in 1984 and 1985. BMJ 1987;294:1001.
3. Le Van Kim C, Mouro I, Chérif-Zahar B, et al. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci U S A 1992;89:10925-9.
4. Colin Y, Chérif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron J-P. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991;78:2747-52.
5. Bennett PR, Le Van Kim C, Colin Y, et al. Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med 1993;329:607-10.
6. Lo YMD, Bowell PJ, Selinger M, et al. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers. Lancet 1993;341:1147-8.
7. Geifman-Holtzman O, Bernstein IM, Berry SM, et al. Fetal RhD genotyping in fetal cells flow sorted from maternal blood. Am J Obstet Gynecol 1996;174:818-22.
8. Sekizawa A, Watanabe A, Kimura T, Saito H, Yanaihara T, Sato T. Prenatal diagnosis of the fetal RhD blood type using a single fetal nucleated erythrocyte from maternal blood. Obstet Gynecol 1996;87:501-5.
9. Toth T, Papp C, Toth-Pal E, Nagy B, Papp Z. Fetal RhD genotyping by analysis of maternal blood: a case report. J Reprod Med 1998;43:219-22.
10. Hamlington J, Cunningham J, Mason G, Mueller R, Miller D. Prenatal detection of rhesus D genotype. Lancet 1997;349:540.
11. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
12. Chen XQ, Stroun M, Magnenat J-L, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-5.
13. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94.
14. Lo YMD, Tein MSC, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-75.
15. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339-237-8. [Erratum, Nature 1989;339:490.]
16. Longo MC, Berninger MS, Hartley JL. Use of uracil DNA glycosylasc to control carry-over contamination in polymerase chain reactions. Gene 1990;93:125-8.
17. The Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis: first report. Lancet 1989;1:1-6.
18. Blakemore KJ, Baumgarten A, Schoenfeld-Dimaio M, Hobbins JC, Mason EA, Mahoney MJ. Rise in maternal serum alpha-fetoprotein concentration after chorionic villus sampling and the possibility of isoimmunization. Am J Obstet Gynecol 1986;155:988-93.
19. Tabor A, Bang J, Norgaard-Pedersen B. Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial. Br J Obstet Gynaecol 1987;94:528-34.
20. Dildy GA, Jackson GM, Ward K. Determination of fetal RhD status from uncultured amniocytes. Obstet Gynecol 1996;88:207-10.
21. Schumacher B, Moise KJ Jr. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996;88:137-50.
22. Robson SC, Lee D, Urbaniak S. Anti-D immunoglobulin in RhD prophylaxis. Br J Obstet Gynaecol 1998;105:129-34.
23. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years post-partum. Proc Natl Acad Sci U S A 1996;93:705-8.
24. Bianchi DW, Flint AF, Pizzimenti MF, Knoll JH, Latt SA. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci U S A 1990;87:3279-83.
25. Cheung MC, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 1996;14:264-8.
26. Chérif-Zahar B, Bloy C, Le Van Kim C, et al. Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc Natl Acad Sci U S A 1990;87:6243-7.
27. Aubin JT, Le Van Kim C, Mouro I, et al. Specificity and sensitivity of RhD genotyping methods by PCR-based DNA amplification. Br J Haematol 1997;98:356-64. .
28. Lo YMD, Fleming KA, Wainscoat JS. Strategies for the detection ot autosomal fetal DNA sequence from maternal peripheral blood. Ann N Y Acad Sci 1994;731:204-13.